Trial Profile
Post-marketing Clinical Study of Onglyza Tablet
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2018
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 01 Dec 2017 Status changed from recruiting to completed.
- 01 Dec 2017 Planned number of patients changed to 210.
- 08 Jun 2016 New trial record